Blog

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by

It was all so different a month ago. Honeywell International (NYSE: HON) reported a good set of fourth-quarter 2019 earnings on the last day of January, and its full-year 2020 guidance for 0%-3%

Over the last few years, the world of retail and related commercial property has been working to insulate itself from the advent of Amazon and the e-commerce movement it helped spur on. Building out

Department stores already faced plenty of challenges -- most notably, ever-rising competition from e-commerce and off-price retailers -- before the COVID-19 pandemic started to sweep across America

Lotteries rake in billions of dollars every year for one simple reason: We all want to be wealthy. But the reality is, lotteries take money from people a lot more often than they give it out. If

Almost every stock has been hit hard in the COVID-19 sell-off. That's creating amazing buying opportunities for investors who have cash that can be quickly deployed.

Which companies are the best

Although markets only began crashing about a month ago, it's difficult to remember a time when the negative financial effects of COVID-19 weren't at the top of everyone's mind. That's the result of

The COVID-19 crisis has already cost millions of Americans their jobs, and the longer it continues, the more likely workers are to keep feeling the pain. Part of the problem, unfortunately, stems

Late Tuesday night, Democrats and Republicans in the Senate stopped arguing, and began agreeing on the details of a planned $2 trillion stimulus deal to save the American economy from coronavirus

Amid the chaos of COVID-19, the rivalry between Home Depot (NYSE: HD) and Lowe's (NYSE: LOW) continues. The two peers have long engaged in a battle to win over more customers in the home improvement

While the stock market has tumbled over the past month as the novel coronavirus outbreak shifted from something happening in China to a global pandemic, certain stocks have bucked the trend. Zoom

Plenty of stocks have cratered in recent weeks as COVID-19 overtook headlines and our way of life. However, amid the coronavirus chaos, buying opportunities have emerged for those bold enough to

The deadline for filing and paying taxes has been extended this year as a result of the COVID-19 coronavirus and resulting business shutdowns. You now have until July 15 to submit your paperwork to

Corporate uniform and facility services company Cintas (NASDAQ: CTAS) is definitely a big loser from the aftermath of the COVID-19 pandemic. The virus is now the cause of a series of abrupt and

Put plainly, it's been a brutal past five weeks for Wall Street and investors. Through just this past weekend, the benchmark S&P 500 had lost 32% of its value in a stretch of just 22 sessions, while

The spread of the novel coronavirus across the globe has brought economic activity to its knees. The COVID-19 disease has infected more than 460,000 people globally as of March 25 and resulted in

The stock market is currently in a state of turmoil, with investors spooked by the COVID-19 pandemic and its potential effects on the global economy. Year to date, the S&P 500 is down by 21% after

Even after a couple of good days for stocks, the S&P 500 is still down almost 26% since late February, wiping out trillions of dollars in wealth as the world faces the biggest health crisis and

Quite a few drugmakers are racing to develop antiviral therapies to combat novel coronavirus disease COVID-19 and vaccines to immunize against infection from the virus. Two of the clear leaders on

There are a lot of stocks that are much cheaper than they've been in a while. That doesn't necessarily make them cheap, though. Think about it this way: Someone could cut the price of a pet rock

Do you have a nice warm-and-fuzzy feeling that the stock market has bottomed out and is ready to roar back? Yeah, me neither. That's not to say that I'm downbeat; I have no doubt whatsoever that a

The rapid societal changes and uncertainty brought about by the COVID-19 pandemic have been a shock to everyone's systems. No one knows how to handle a situation like this, and that can lead some to

The Senate and White House have agreed to the terms of a $2 trillion stimulus bill designed to mitigate the economic damage caused by the coronavirus pandemic. While much of the bill is designed to

Everyone wants the answer to this question these days. As the expanding coronavirus pandemic pushed the market into bear territory earlier this month, investors fled from stocks across industries

Behemoth biotech Gilead Sciences (NASDAQ: GILD) announced on March 2 that it will acquire up-and-coming cancer drug developer Forty Seven (NASDAQ: FTSV) for $4.9 billion. Biotech investors had been